Thomas Stankovich - Chief Financial Officer, Reshape Lifesciences Inc

As of May 12, 2022


Thomas Stankovich Net Worth

  • Net worth is estimated to be at least $9.93K
  • Owns at least 345,627 units of Reshape Lifesciences Inc stock
  • Sold an estimated value of $192.56K in the last 2 years at Reshape Lifesciences Inc

Thomas Stankovich Trading

  • Largest purchase of shares was 15,000 units , worth over $51.44K on August 31, 2021
  • Largest sale of shares was 48,366 units , worth over $139.78K on September 17, 2021
  • In total has made about 14 transactions over 2 years
  • Usually trades in August, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Thomas Stankovich Mailing Address

  • Mailing address is 1001 Calle Amanecer San Clemente CA 92673 CA

Reshape Lifesciences Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
William Plovanic 2019 $422,917 $241,000 - $290,708 - $994 $955,619
William Plovanic 2018 $400,000 $155,000 $127,350 $381,710 - $949 $1,065,009
Andrew Rasdal 2019 $325,000 - $200,001 - - $994 $525,995
Andrew Rasdal 2018 $650,000 $520,000 - $1,145,130 - $978 $2,316,108
Mark Brister 2019 $367,500 $35,000 - $139,180 - $994 $542,674
Kelly Huang 2019 $202,331 - - $376,560 - $277,491 $856,382
Kelly Huang 2018 $432,000 - $183,950 $305,368 $199,800 $4,242 $1,125,360
Amy Vandenberg 2019 $367,500 $35,000 - $136,028 - $994 $539,522
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1427570/000142757020000051/obln2020def14a.htm

Reshape Lifesciences Inc Insider Trading

  • The most recent transaction was 11,417 units sold on May 12, 2022 by Barton P Bandy worth over $8.79K
  • In the last 5 years, insiders at Reshape Lifesciences Inc sold an estimated value of $16.02M and bought an estimated value of $1.38M
  • The most active traders are Armistice Capital Llc,  Steven Boyd,  and Armistice Capital Master Fund Ltd
  • Insider trading is most common in September, with the busiest year in 2019

ReShape Lifesciences Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1